Gene · 5890
Papers1,861
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,861
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma. | Mod Pathol | 2023 | 37423587 | PubTator, text mining | PubMed |
| Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience. | J Gynecol Oncol | 2023 | 37417298 | PubTator, text mining | PubMed |
| The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment. | Front Oncol | 2023 | 37409248 | PubTator, text mining | PubMed |
| Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers. | Cells | 2023 | 37408210 | PubTator, text mining | PubMed |
| A Glimpse into the Genome-wide DNA Methylation Changes in 6-hydroxydopamine-induced In Vitro Model of Parkinson's Disease. | Exp Neurobiol | 2023 | 37403221 | PubTator, text mining | PubMed |
| QTL mapping of human retina DNA methylation identifies 87 gene-epigenome interactions in age-related macular degeneration. | Res Sq | 2023 | 37398472 | PubTator, text mining | PubMed |
| Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs. | Res Rep Urol | 2023 | 37396015 | PubTator, text mining | PubMed |
| Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice. | Cancers (Basel) | 2023 | 37370804 | PubTator, text mining | PubMed |
| A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. | Oncologist | 2023 | 37354528 | PubTator, text mining | PubMed |
| Structural insights into BCDX2 complex function in homologous recombination. | Nature | 2023 | 37344589 | PubTator, text mining | PubMed |
| Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor. | Nature | 2023 | 37344587 | PubTator, text mining | PubMed |
| Characterization of global research trends and prospects on platinum-resistant ovarian cancer: a bibliometric analysis. | Front Oncol | 2023 | 37342181 | PubTator, text mining | PubMed |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer. | Sci Rep | 2023 | 37336919 | PubTator, text mining | PubMed |
| Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression. | Clin Cancer Res | 2023 | 37327320 | PubTator, text mining | PubMed |
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study. | Cancers (Basel) | 2023 | 37296992 | PubTator, text mining | PubMed |
| Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges. | Cancers (Basel) | 2023 | 37296848 | PubTator, text mining | PubMed |
| HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies. | J Transl Med | 2023 | 37296466 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia. | Blood Cancer J | 2023 | 37286545 | PubTator, text mining | PubMed |
| Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. | Nat Med | 2023 | 37277454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5890/papers?page=11